Name | Cvs Pharmacy #01060 |
---|---|
Organization Name | Connecticut Cvs Pharmacy Llc |
Location | 326 Main St, Southington, Connecticut 06489 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Phone | (860) 621-1996 |
Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Ingen Technologies, Inc., an emerging medical device manufacturer developing innovative solutions for the respiratory market, with a new patented and proprietary medical product line targeting the $8B respiratory market, announced today that the company revenues have increased from $10,401 reported in May 31, 2009, to $128,917 ending May 31, 2010. This is an increase of 1,139%.
Low-density lipoprotein cholesterol levels should be lowered as much as possible to prevent cardiovascular disease, especially in high and very high risk patients.
Carbon nanotubes hold many exciting possibilities, some of them in the realm of the human nervous system. Recent research has shown that carbon nanotubes may help regrow nerve tissue or ferry drugs used to repair damaged neurons associated with disorders such as epilepsy, Parkinson's disease and perhaps even paralysis.
Advaxis, Inc., the live, attenuated Listeria monocytogenes (Lm) immunotherapy company, has updated the survival information from its phase 1 trial of ADXS11-001 which assessed the safety of this agent in advanced, metastatic, progressive cervix cancer in women whose disease progressed subsequent to treatment with cytotoxic therapy.
› Verified 7 days ago
NPI Number | 1972607877 |
Organization Name | CONNECTICUT CVS PHARMACY LLC |
Doing Business As | CVS PHARMACY #01060 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Address | 326 Main St, Southington, CT 06489 |
Phone Number | 860-621-1996 |
News Archive
Ingen Technologies, Inc., an emerging medical device manufacturer developing innovative solutions for the respiratory market, with a new patented and proprietary medical product line targeting the $8B respiratory market, announced today that the company revenues have increased from $10,401 reported in May 31, 2009, to $128,917 ending May 31, 2010. This is an increase of 1,139%.
Low-density lipoprotein cholesterol levels should be lowered as much as possible to prevent cardiovascular disease, especially in high and very high risk patients.
Carbon nanotubes hold many exciting possibilities, some of them in the realm of the human nervous system. Recent research has shown that carbon nanotubes may help regrow nerve tissue or ferry drugs used to repair damaged neurons associated with disorders such as epilepsy, Parkinson's disease and perhaps even paralysis.
Advaxis, Inc., the live, attenuated Listeria monocytogenes (Lm) immunotherapy company, has updated the survival information from its phase 1 trial of ADXS11-001 which assessed the safety of this agent in advanced, metastatic, progressive cervix cancer in women whose disease progressed subsequent to treatment with cytotoxic therapy.
› Verified 7 days ago
News Archive
Ingen Technologies, Inc., an emerging medical device manufacturer developing innovative solutions for the respiratory market, with a new patented and proprietary medical product line targeting the $8B respiratory market, announced today that the company revenues have increased from $10,401 reported in May 31, 2009, to $128,917 ending May 31, 2010. This is an increase of 1,139%.
Low-density lipoprotein cholesterol levels should be lowered as much as possible to prevent cardiovascular disease, especially in high and very high risk patients.
Carbon nanotubes hold many exciting possibilities, some of them in the realm of the human nervous system. Recent research has shown that carbon nanotubes may help regrow nerve tissue or ferry drugs used to repair damaged neurons associated with disorders such as epilepsy, Parkinson's disease and perhaps even paralysis.
Advaxis, Inc., the live, attenuated Listeria monocytogenes (Lm) immunotherapy company, has updated the survival information from its phase 1 trial of ADXS11-001 which assessed the safety of this agent in advanced, metastatic, progressive cervix cancer in women whose disease progressed subsequent to treatment with cytotoxic therapy.
› Verified 7 days ago
Cvs Pharmacy #01028 Type: Medicare Supplier Location: 724 Queen St, Southington, Connecticut 06489 Phone: (860) 621-7371 | |
Cvs Pharmacy #01060 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 326 Main St, Southington, Connecticut 06489 Phone: (860) 621-1996 | |
Cvs Pharmacy #17491 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 600 Executive Blvd, Southington, Connecticut 06489 Phone: (860) 406-6755 | |
Ct Support Services Holdings Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 786 W Queen St, Southington, Connecticut 06489 Phone: (860) 426-9868 | |
Beacon Prescriptions Type: Durable Medical Equipment & Medical Supplies Supplier Location: 609 N Main St, Southington, Connecticut 06489 Phone: (860) 628-3972 |